In adults aged 76 to 85, colorectal cancer screening should be which of the following?

In adults aged 76 to 85, colorectal cancer screening should be which of the following?

• A. Continued screening every year regardless of health
• B. Individualized based on health and prior screening history
• C. Screen for everyone at this age with colonoscopy
• D. Stop screening after age 75

Answer: (B)

Colorectal cancer screening in adults 76–85 is about balancing potential benefit with potential harm, based on how healthy the person is and what their past screening history looks like. In this age group, the extra years of life a person has to gain from early cancer detection are the key factor. If someone is in good overall health with a reasonable life expectancy and has not had recent appropriate screening, continuing screening can still be beneficial. On the other hand, for someone with significant comorbidities, frailty, or limited life expectancy, the chances that screening will improve outcomes are small and the risks or burdens of procedures become more consequential. Because of this, the best approach is individualized decision-making: discuss the potential benefits and harms with the patient, consider prior screening results and intervals, and tailor the plan to their health status and preferences rather than applying a blanket rule.

Colorectal cancer screening in adults 76–85 is about balancing potential benefit with potential harm, based on how healthy the person is and what their past screening history looks like. In this age group, the extra years of life a person has to gain from early cancer detection are the key factor. If someone is in good overall health with a reasonable life expectancy and has not had recent appropriate screening, continuing screening can still be beneficial. On the other hand, for someone with significant comorbidities, frailty, or limited life expectancy, the chances that screening will improve outcomes are small and the risks or burdens of procedures become more consequential.

Because of this, the best approach is individualized decision-making: discuss the potential benefits and harms with the patient, consider prior screening results and intervals, and tailor the plan to their health status and preferences rather than applying a blanket rule.